# Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant

> **NCT03649074** · NA · COMPLETED · sponsor: **Akili Interactive Labs, Inc.** · enrollment: 206 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DEVICE:** AKL-T01

## Key facts

- **NCT ID:** NCT03649074
- **Lead sponsor:** Akili Interactive Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-28
- **Primary completion:** 2019-09-23
- **Final completion:** 2019-09-23
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649074, "Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03649074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*